logo
Plus   Neg
Share
Email

Roche To Present New Data From Neuroscience Portfolio at 2019 AAN Annual Meeting

Swiss drug major Roche (RHHBY) said that it will present new data for its approved and investigational medicines for the treatment of neurological conditions at the 71st American Academy of Neurology Annual Meeting from 4-10 May in Philadelphia, PA.

Presentations will include data from a pivotal study of its investigational drug Risdiplam in spinal muscular atrophy, new data of its approved drug OCREVUS in relapsing and primary progressive multiple sclerosis, and that of its investigational medicines like Satralizumab in neuromyelitis optica spectrum disorder (NMOSD), RG6042 in Huntington's disease (HD), Gantenerumab and RO7105705 in Alzheimer's disease and RG6206 in Duchenne muscular dystrophy.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A survey has shown that while a majority of Americans want to buy a car that contributes substantially to the U.S. economy amid rising trade tensions, most of the "American-made" cars are actually produced by foreign automakers. According to Cars.com's 2019 American-Made Index, the most 'American-made' vehicle in 2019 is the Jeep Cherokee. Streaming giant Netflix Inc. (NFXL) is set to lose the right to stream "The Office," one of the most popular TV show on the service. NBC Universal announced it is taking back the popular TV show for its own streaming platform, beginning January 2021. "We're sad that NBC has decided to take The... Chinese smartphone maker Xiaomi has announced that its recently launched Mi Band 4 crossed 1 million units sales in just eight days. Xiaomi's Director of Product Management Donovan Sung tweeted this news as he thanked Mi fans for the achievement. "Sharing some great news with our global Mi Fans....
Follow RTT